Arrowhead Pharmaceuticals (ARWR) had the highest return in November 2019 by a mid-cap US stock or mid-cap US stock, returning 81.2%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Arrowhead Pharmaceuticals (ARWR) | November 2019 | 81.21% |
Surgery Partners (SGRY) | November 2019 | 71.82% |
Axsome Therapeutics (AXSM) | November 2019 | 62.42% |
Immunitybio (IBRX) | November 2019 | 60.75% |
CleanSpark (CLSK) | November 2019 | 60% |
89bio (ETNB) | November 2019 | 56.35% |
American Bitcoin (ABTC) | November 2019 | 52.56% |
Kiniksa Pharmaceuticals (KNSA) | November 2019 | 50.21% |
Peloton Interactive (PTON) | November 2019 | 47.59% |
Plug Power (PLUG) | November 2019 | 44.44% |
Crispr Therapeutics (CRSP) | November 2019 | 39.59% |
Xenon Pharmaceuticals (XENE) | November 2019 | 37.56% |
Synaptics (SYNA) | November 2019 | 36.78% |
Krystal Biotech (KRYS) | November 2019 | 36.46% |
Merit Medical Systems (MMSI) | November 2019 | 34.55% |
DXC Technology (DXC) | November 2019 | 34.52% |
Sitime (SITM) | November 2019 | 33.85% |
Sarepta Therapeutics (SRPT) | November 2019 | 32.34% |
Intellia Therapeutics (NTLA) | November 2019 | 31.49% |
Buckle (BKE) | November 2019 | 31.17% |
Victory Capital (VCTR) | November 2019 | 30.55% |
Ondas (ONDS) | November 2019 | 30% |
Agios Pharm (AGIO) | November 2019 | 26.67% |
Halozyme Therapeutics (HALO) | November 2019 | 26.57% |
National Vision (EYE) | November 2019 | 26.52% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
